Moscow, Aug 1 (UNI) Russian Health Minister Mikhail Murashko on Saturday said that clinical trials of a COVID-19 vaccine, developed by the Gamaleya Institute of Epidemiology and Microbiology, have been completed.
"The vaccine against Coronavirus infection, developed by the Gamaleya Institute, has completed clinical trials," Mr Murashko said, adding that paperwork is underway for it's registration.
He noted that the documents for vaccine registration is being prepared.
According to Mr Murashko, 'We expect at least two more applications in the next one and a half to two months for permission to conduct clinical trials.'
The Health Ministry plans a mass vaccination campaign against the Coronavirus for October, he said.
'We plan wider [vaccination] for October because we need to launch a new system of treatment gradually,' TASS quoted the Minister as saying.
Meanwhile, the country registered 5,462 COVID-19 cases in the past 24 hours (5,482 on Friday), bringing the cumulative total to 845,443, the country's coronavirus response center said. A total of 95 COVID-19 patients died in Russia in the past 24 hours (161 on the previous day), which brings the death toll to 14,058.
UNI JAL RJ 2040